A Study of sEphB4-HSA in Kaposi Sarcoma
Clinical trial NCT03993106 · UNKNOWN
Trial details
- NCT number
- NCT03993106
- Sponsor
- Vasgene Therapeutics, Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2024-12-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.